WO1987003476A1 - Composition for the treatment of periodontal disease - Google Patents

Composition for the treatment of periodontal disease Download PDF

Info

Publication number
WO1987003476A1
WO1987003476A1 PCT/US1986/002625 US8602625W WO8703476A1 WO 1987003476 A1 WO1987003476 A1 WO 1987003476A1 US 8602625 W US8602625 W US 8602625W WO 8703476 A1 WO8703476 A1 WO 8703476A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyldimethylbenzylammonium
periodontal disease
mouthwash
chlorides
treatment
Prior art date
Application number
PCT/US1986/002625
Other languages
French (fr)
Inventor
Christian Schwabe
Original Assignee
Micro-Map, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micro-Map, Inc. filed Critical Micro-Map, Inc.
Publication of WO1987003476A1 publication Critical patent/WO1987003476A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/416Quaternary ammonium compounds

Definitions

  • composition for the treatment of periodontal disease Composition for the treatment of periodontal disease
  • This invention relates to a method and composition for the non-invasive treatment of periodontal disease, including periodontitis and related forms of gingival disease by topical application of alkyldimethylbenzylammonium chlorides.
  • Periodontal disease involves inflammation of gingival tissues in response to the actions of oral bacteria.
  • the gingiva appear red and swollen, and have a tendency to bleed when the teeth are brushed.
  • the attachment between the gums and the tooth may be broken. This creates a space, or periodontal pocket, between the tooth and gum which can serve as a center for enhanced microbial growth.
  • Such growth can lead to the formation of abscesses and bone loss in the alveolar crest.
  • the consequence of advanced periodontal disease is a loosening of the teeth and ultimately extraction is required.
  • Prophylactic measures can be taken to forestall the occurrence, or reoccurrence of periodontal disease.
  • Known prophylactic measures include the regular use of dental floss. Such measures are generally time consuming and involve a strict regimen of home care to be effective. For this reason, known prophylactic measures are rarely completely effective in preventing periodontal disease.
  • Anti-bacterial mouthwashes have been disclosed which are believed to be effective in the prevention or minimization of plaque.
  • some quaternary amines including benzethonium chloride. These preparations are not known to be effective, however, in the treatment of periodontal disease, and are of only limited effectiveness as a prophylactic measure.
  • an object of this invention to provide a method and composition for the treatment and prevention of periodontal disease.
  • Periodontal disease can be effectively treated by topical application of alkyldimethylbenzylammonium chlorides, where the alkyl groups are straight chains of from 12 to 18 carbon atoms.
  • alkyldimethylbenzylammonium chlorides leads to a reduction in the number of live microorganisms present in the oral cavity and to a reduction of gingival inflammation.
  • Treatment of extant inflammations is accomplished using a mouthwash containing from 0.1% to 0.2% of the alkyldimethylbenzylammonium chloride,
  • the mouthwash is preferably used twice daily, following lunch and after the last food of the day.
  • Toothpaste preparations containing alkyldimethylbenzylammonium chloride can be effectively used to prevent inflammation of the oral gingiva and periodontal disease.
  • the alkyldimethylbenzylammonium chloride is preferably incorporated into the toothpaste at a concentration of about 0.1%.
  • Alkyldimethylbenzylammonium chlorides are routinely available from drug stores and hospital supply companies for use in cold sterilization of surgical instruments. It has now been found that these compounds are effective in the treatment and prevention of periodontal disease.
  • alkyldimethylbenzylammonium chloride where the alkyl group is a straight chain of from 12 to 18 carbon atoms, is applied topically to the gingival tissues to treat and prevent periodontal disease.
  • Each of the alkyldimethylbenzylammonium chlorides is effective when used alone, and when used as a mixture.
  • the treatment involves application of an equimolar mixture of alkyldimethylbenzylammonium chlorides having an alkyl substituent of from 12 to 18 carbon atoms in length.
  • alkyldimethylbenzylammonium chloride is preferably applied as a mouthwash.
  • the alkyldimethylbenzylammonium chloride is dissolved in water to form a mouthwash capable of killing oral bacteria on contact.
  • the mouthwash contains from 0.1% to 0.2% alkyldimethylbenzylammonium chloride. higher concentrations are not required for therapeutic effectiveness, and are not recommended due to the bitter taste of the active ingredient.
  • a mouthwash according to this invention may also contain other ingredients conventionally included in mouthwash formulations, including flavorants, colorants, and astringents. It will also be understood that a mouthwash according to this invention can be formulated as a gel, as well as a liquid.
  • a mouthwash according to this invention is used regularly to treat periodontal disease until redness and swelling of the gums are alleviated.
  • the mouthwash is applied twice daily, following lunch and after the last food of the day.
  • a portion of the active ingredient adsorbs to the surface of the teeth, resulting in prolonged effectiveness.
  • Reduction of gingival inflammation generally results within one week of the onset of treatment, and in some cases may be effected with only a single application.
  • Alkyldimethylbenzylammonium chloride can be applied to the gums and teeth by simply swishing the mouthwash around in the oral cavity. Preferably, contact with the mouthwash is maintained for from 5 to 15 seconds.
  • the mouthwash may also be advantageously introduced into the lumen of a periodontal pocket or abscess using a blunt-needled syringe.
  • alkyldimethylbenzylammonium chloride may be applied either in a mouthwash or in a toothpaste.
  • a toothpaste according to this invention Preferably contains 0.1% alkyldimethylbenzylammonium chloride in an otherwise conventional toothpaste formulation. Such a toothpaste used regularly will effectively prevent the onset of periodontal disease. The following case studies will serve to illustrate the use and effectiveness of compositions according to this invention.
  • the patient diagnosed as having progressive periodontal symptoms was scheduled for periodontal treatment involving local surgical intervention.
  • the patient was given a mouthwash containing 0.2% alkyldimethylbenzylammonium chloride (40% C 12 ; 50% C 1 4 ; 10% C 16 ) according to this invention which was used once daily after the last meal for a period of one week prior to the scheduled appointment.
  • alkyldimethylbenzylammonium chloride as directed eliminated the need for any surgical intervention in the opinion of the periodontologist who had initially recommended surgery.
  • This patient had a periodontal abscess in the region of the upper left molar.
  • the patient was given a syringe with a blunt needle and advised to flush out the abscess with an 0.2% solution of alkyldimethylbenzylammonium chlorides (40% C 12 ; 50% C 14 ; 10% C 16 ).
  • the symptoms disappeared within one hour, and have not recur red af ter three months during which time a prophylactic amount of the compound was used occasionally in the form of an 0.2% mouthwash once every three days.
  • compositions according to this invention give excellent results when used in the treatment and prevention of periodontal disease. It will be understood, however, that in very advanced cases of periodontal disease surgical intervention may still be necessary. In these circumstances, compositions containing alkyldimethylbenzylammonium chloride are advantageously used to reduce gingival inflammation prior to surgery and as a prophylactic regimen following surgery.

Abstract

Periodontal disease is effectively treated by topical application of alkyldimethylbenzylammonium chlorides having as the alkyl group a straight chain of from 12 to 18 carbon atoms. The preferred therapeutic agent is an equimolar mixture of these compounds. Treatment can be effected using a mouthwash containing from 0.1% to 0.2% alkyldimethylbenzylammonium chloride. Prophylactic applications, particularly using a toothpaste carrier, are also effective.

Description

Description
Composition for the treatment of periodontal disease
Background of the Invention
This invention relates to a method and composition for the non-invasive treatment of periodontal disease, including periodontitis and related forms of gingival disease by topical application of alkyldimethylbenzylammonium chlorides.
Periodontal disease involves inflammation of gingival tissues in response to the actions of oral bacteria. The gingiva appear red and swollen, and have a tendency to bleed when the teeth are brushed. As the disease progresses, the attachment between the gums and the tooth may be broken. This creates a space, or periodontal pocket, between the tooth and gum which can serve as a center for enhanced microbial growth. Such growth can lead to the formation of abscesses and bone loss in the alveolar crest. The consequence of advanced periodontal disease is a loosening of the teeth and ultimately extraction is required.
Current methods of treatment of periodontal disease depend on the severity of the disease. Mild cases are generally treated by the removal of mechanical irritants such as calculus. More severe cases are treated surgically by removal of gingival tissue, polishing of tooth roots, or occasionally by splinting of the teeth. Surgical intervention is a painful and costly procedure, however, and should be avoided if at all possible.
Prophylactic measures can be taken to forestall the occurrence, or reoccurrence of periodontal disease. Known prophylactic measures include the regular use of dental floss. Such measures are generally time consuming and involve a strict regimen of home care to be effective. For this reason, known prophylactic measures are rarely completely effective in preventing periodontal disease.
Anti-bacterial mouthwashes have been disclosed which are believed to be effective in the prevention or minimization of plaque. Among the known antibacterials are some quaternary amines including benzethonium chloride. These preparations are not known to be effective, however, in the treatment of periodontal disease, and are of only limited effectiveness as a prophylactic measure.
It is therefore, an object of this invention to provide a method and composition for the treatment and prevention of periodontal disease.
It is a further object of this invention to provide a method and composition for the treatment and prevention of periodontal disease which is easily and rapidly administered by the user.
Summary of the Invention
Periodontal disease can be effectively treated by topical application of alkyldimethylbenzylammonium chlorides, where the alkyl groups are straight chains of from 12 to 18 carbon atoms. Application of alkyldimethylbenzylammonium chlorides leads to a reduction in the number of live microorganisms present in the oral cavity and to a reduction of gingival inflammation.
Treatment of extant inflammations is accomplished using a mouthwash containing from 0.1% to 0.2% of the alkyldimethylbenzylammonium chloride, The mouthwash is preferably used twice daily, following lunch and after the last food of the day.
Toothpaste preparations containing alkyldimethylbenzylammonium chloride can be effectively used to prevent inflammation of the oral gingiva and periodontal disease. The alkyldimethylbenzylammonium chloride is preferably incorporated into the toothpaste at a concentration of about 0.1%. Detailed Description of the Invention
Alkyldimethylbenzylammonium chlorides are routinely available from drug stores and hospital supply companies for use in cold sterilization of surgical instruments. It has now been found that these compounds are effective in the treatment and prevention of periodontal disease.
According to the invention, alkyldimethylbenzylammonium chloride, where the alkyl group is a straight chain of from 12 to 18 carbon atoms, is applied topically to the gingival tissues to treat and prevent periodontal disease. Each of the alkyldimethylbenzylammonium chlorides is effective when used alone, and when used as a mixture. Preferably, the treatment involves application of an equimolar mixture of alkyldimethylbenzylammonium chlorides having an alkyl substituent of from 12 to 18 carbon atoms in length.
For treatment of existing periodontal disease, alkyldimethylbenzylammonium chloride is preferably applied as a mouthwash. For this purpose, the alkyldimethylbenzylammonium chloride is dissolved in water to form a mouthwash capable of killing oral bacteria on contact. Preferably, the mouthwash contains from 0.1% to 0.2% alkyldimethylbenzylammonium chloride. higher concentrations are not required for therapeutic effectiveness, and are not recommended due to the bitter taste of the active ingredient.
A mouthwash according to this invention may also contain other ingredients conventionally included in mouthwash formulations, including flavorants, colorants, and astringents. It will also be understood that a mouthwash according to this invention can be formulated as a gel, as well as a liquid.
A mouthwash according to this invention is used regularly to treat periodontal disease until redness and swelling of the gums are alleviated. Preferably, the mouthwash is applied twice daily, following lunch and after the last food of the day. A portion of the active ingredient adsorbs to the surface of the teeth, resulting in prolonged effectiveness. Reduction of gingival inflammation generally results within one week of the onset of treatment, and in some cases may be effected with only a single application.
Alkyldimethylbenzylammonium chloride can be applied to the gums and teeth by simply swishing the mouthwash around in the oral cavity. Preferably, contact with the mouthwash is maintained for from 5 to 15 seconds. The mouthwash may also be advantageously introduced into the lumen of a periodontal pocket or abscess using a blunt-needled syringe.
For prophylactic use, alkyldimethylbenzylammonium chloride may be applied either in a mouthwash or in a toothpaste. A toothpaste according to this invention Preferably contains 0.1% alkyldimethylbenzylammonium chloride in an otherwise conventional toothpaste formulation. Such a toothpaste used regularly will effectively prevent the onset of periodontal disease. The following case studies will serve to illustrate the use and effectiveness of compositions according to this invention. Example 1
The patient diagnosed as having progressive periodontal symptoms was scheduled for periodontal treatment involving local surgical intervention. The patient was given a mouthwash containing 0.2% alkyldimethylbenzylammonium chloride (40% C12 ; 50% C1 4; 10% C16) according to this invention which was used once daily after the last meal for a period of one week prior to the scheduled appointment. The use of alkyldimethylbenzylammonium chloride as directed eliminated the need for any surgical intervention in the opinion of the periodontologist who had initially recommended surgery. Example 2
The patient had a longstanding history of chronic gingivitis which led to bleeding of the gums and considerable discomfort after every use of the toothbrush. Treatment with an 0.2% alkyldimethylbenzylammonium chloride mouthwash (40% C12; 50% C14; 10% C16) at noon and following the last meal of the day eliminated the gingivitis completely. In three days, the patient could brush her teeth without causing any bleeding or discomfort. Example 3
This patient had a periodontal abscess in the region of the upper left molar. The patient was given a syringe with a blunt needle and advised to flush out the abscess with an 0.2% solution of alkyldimethylbenzylammonium chlorides (40% C12; 50% C14; 10% C16). The symptoms disappeared within one hour, and have not recur red af ter three months during which time a prophylactic amount of the compound was used occasionally in the form of an 0.2% mouthwash once every three days.
Compositions according to this invention give excellent results when used in the treatment and prevention of periodontal disease. It will be understood, however, that in very advanced cases of periodontal disease surgical intervention may still be necessary. In these circumstances, compositions containing alkyldimethylbenzylammonium chloride are advantageously used to reduce gingival inflammation prior to surgery and as a prophylactic regimen following surgery.
The method and composition embodiments described above are intended only to be illustrative. It will be understood that modifications in form and detail may be made within the scope of the following claims.

Claims

Claims
1. A method for treating periodontal disease comprising topical application of one or more alkyldimethylbenzylammonium chlorides having as the alkyl group a straight chain of from 12 to 18 carbon atoms.
2. A method according to claim 1, comprising topical application of an equimolar mixture of alkyldimethylbenzylammonium chlorides having as the alkyl group a straight chain of from 12 to 18 carbon atoms.
3. A method according to claim 1 comprising application of a mixture of 40% C12, 50% C14, 10% C16 alkyldimethylbenzylammonium chlorides.
4. A method according to claim 1, wherein the alkyldimethylbenzylammonium chloride is applied as a mouthwash.
5. A method according to claim 4, wherein the mouthwash comprises from 0.1% to 0.2% alkyldimethylbenzylammonium chloride in aqueous solution.
6. A method according to claim 5, wherein the mouthwash is applied twice daily.
7. A method according to claim 1, wherein the treatment is preventative.
8. A method according to claim 7, wherein the alkyldimethylbenzylammonium chloride is incorporated in a toothpaste.
9. A method according to claim 8, wherein the alkyldimethylbenzylammonium chloride is present in the toothpaste at a concentration of 0.1%.
10. A composition for treating periodontal disease comprising one or more alkyldimethylbenzylammonium chlorides having as the alkyl group a straight chain of from 12 to 18 carbon atoms in an amount effective to kill oral bacteria on contact, and a non-toxic carrier.
11. A composition according to claim 9 comprising an equimolar mixture of alkyldimethylbenzylammonium chlorides having as the alkyl group a straight chain of from 12 to 18 carbon atoms.
12. A composition according to claim 1 comprising a mixture consisting of 40% C12, 50% C14, 10% C1 6 alkyldimethylbenzylammonium chlorides and a nontoxic carrier.
13. A composition according to claim 10, wherein the carrier is water.
14. A composition according to claim 13, wherein the alkyldimethylbenzylammonium chloride is present at a concentration of from 0.1% to 0.2%.
15. A composition according to claim 13 additionally comprising one or more ingredients selected from the group consisting of flavorants, colorants and astringents.
16. A composition according to claim 10, wherein the carrier is a toothpaste.
17. A composition according to claim 16, wherein the alkyldimethylbenzylammonium chloride is present at a concentration of about 0.1%.
PCT/US1986/002625 1985-12-13 1986-12-05 Composition for the treatment of periodontal disease WO1987003476A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80849885A 1985-12-13 1985-12-13
US808,498 1985-12-13

Publications (1)

Publication Number Publication Date
WO1987003476A1 true WO1987003476A1 (en) 1987-06-18

Family

ID=25198946

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1986/002625 WO1987003476A1 (en) 1985-12-13 1986-12-05 Composition for the treatment of periodontal disease

Country Status (2)

Country Link
EP (1) EP0250547A1 (en)
WO (1) WO1987003476A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5176901A (en) * 1991-04-10 1993-01-05 Smithkline Beecham Corporation Dental composition
WO1999025190A1 (en) * 1997-11-18 1999-05-27 Woodward Laboratories, Inc. Surfactant-based antimicrobial compositions and methods for using same
US6479039B1 (en) 1999-07-13 2002-11-12 Woodward Laboratories, Inc. Antimicrobial artificial nail composition and methods for preparing and using same

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2282861A1 (en) * 1974-08-26 1976-03-26 Blendax Werke Schneider Co TOOTH AND MOUTH CARE PRODUCTS
DE2600708A1 (en) * 1975-01-15 1976-07-22 Colgate Palmolive Co PREPARATIONS FOR ORAL AND DENTAL CARE
US4021537A (en) * 1973-08-09 1977-05-03 Research Lab Products, Inc. Oral bactericidal compositions
GB1544536A (en) * 1975-12-12 1979-04-19 Colgate Palmolive Co Dentifrices
EP0059012A2 (en) * 1981-02-19 1982-09-01 THE PROCTER & GAMBLE COMPANY Mouthwash compositions
US4370314A (en) * 1975-12-08 1983-01-25 Colgate-Palmolive Company Oral composition containing antibacterial agent

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021537A (en) * 1973-08-09 1977-05-03 Research Lab Products, Inc. Oral bactericidal compositions
FR2282861A1 (en) * 1974-08-26 1976-03-26 Blendax Werke Schneider Co TOOTH AND MOUTH CARE PRODUCTS
DE2600708A1 (en) * 1975-01-15 1976-07-22 Colgate Palmolive Co PREPARATIONS FOR ORAL AND DENTAL CARE
US4370314A (en) * 1975-12-08 1983-01-25 Colgate-Palmolive Company Oral composition containing antibacterial agent
GB1544536A (en) * 1975-12-12 1979-04-19 Colgate Palmolive Co Dentifrices
EP0059012A2 (en) * 1981-02-19 1982-09-01 THE PROCTER & GAMBLE COMPANY Mouthwash compositions

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5176901A (en) * 1991-04-10 1993-01-05 Smithkline Beecham Corporation Dental composition
WO1999025190A1 (en) * 1997-11-18 1999-05-27 Woodward Laboratories, Inc. Surfactant-based antimicrobial compositions and methods for using same
US6087400A (en) * 1997-11-18 2000-07-11 Woodward Laboratories, Inc. Surfactant-based antimicrobial compositions and methods for using same
US6479039B1 (en) 1999-07-13 2002-11-12 Woodward Laboratories, Inc. Antimicrobial artificial nail composition and methods for preparing and using same
US7244418B2 (en) 1999-07-13 2007-07-17 Woodward Laboratories, Inc. Antimicrobial artificial nail composition and methods for preparing and using same

Also Published As

Publication number Publication date
EP0250547A1 (en) 1988-01-07

Similar Documents

Publication Publication Date Title
Rees et al. Oral ulcerations with use of hydrogen peroxide
Mandel Antimicrobial mouthrinses: overview and update
Pistorius et al. Efficacy of subgingival irrigation using herbal extracts on gingival inflammation
Keijser et al. Comparison of 2 commercially available chlorhexidine mouthrinses
Ernst et al. The effectiveness and side effects of 0.1% and 0.2% chlorhexidine mouthrinses: a clinical study.
Boyd et al. Eighteen-month evaluation of the effects of a 0.4% stannous fluoride gel on gingivitis in orthodontic patients
US3651208A (en) Dentifrice for periodontia purposes
US20080057007A1 (en) Oral hygiene products containing ascorbic acid and method of using the same
US8303938B2 (en) Anti-calculus dental composition
EP0423266A1 (en) Method and composition for treatment of periodontal disease
AU732509B2 (en) Agents for the promotion of oral hygiene and oral health
US6589513B2 (en) Oral hygiene formulation and method of use
US4400373A (en) Method for treating gingival and periodontal tissues
US5827503A (en) Method and composition for treating periodontitis
US20190167544A1 (en) Dual Compnent Oral Composition for Enhancing Remineralization of Teeth
WO1987003476A1 (en) Composition for the treatment of periodontal disease
EP1000616A1 (en) Prevention and treatment of parodontitis
JPH01502111A (en) Oral hygiene medicine
Manonmanipavithra et al. A review on chlorhexidine in periodontal therapy
Zabokova-Bilbilova et al. Clinical Study on the Effect of Chlorhexidine Mouth Rinse in Improving Oral Health in Orthodontic Patients with Fixed Appliances
US20210379045A1 (en) Antibacterial pro-coagulant formula
EP1274395A1 (en) New formulations for the removal of dental plaque, tartar and dental stains
Pawar et al. Effectiveness of Chlorhexidine Varnish on the Prevention of Root Caries: A Narrative Review
RU2121338C1 (en) Method of complex treatment of patients with parodontium sickness
Sohi et al. Fresh Mouth is a Gateway to a Healthy Body–An Overview of Current Use of Chlorhexidine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE